Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene ...

President-elect Donald Trump has picked a prominent vaccine skeptic to lead the nation’s sprawling public health apparatus.

This pioneering vaccine represents a major advancement in our fight against HIV/AIDS. The success highlights our role as one ...

A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...

On November 6, Americans woke up to the news that Donald Trump had defeated Kamala Harris in the presidential election, thus ...

Genetic vaccines, sometimes called naked-DNA vaccines, are currently being developed to fight diseases such as AIDS. The goal of these vaccines is to use a gene from a pathogen to generate an ...

Jon Cohen has presented a provocative and remarkably detailed account of the first 20 years of the quest towards an AIDS vaccine. In 1981, it was a new disease. By 1983, there was a causative ...

Whereas federal expenditure in the United States on the development of an HIV/AIDS vaccine is approximately $250 million, only $25 million is spent on research and development for a malaria vaccine.

The polio vaccine doesn't prevent infection with polio ... Combinations of antiviral drugs—the AIDS cocktails—can prolong life for many patients. Baltimore: It's interesting.

Gay men are more trusting of medicine than other groups, but the incoming Trump Administration will need more than their ...

Understanding the structure-function relationship in respect to the exogenous roles of Tat may have important clinical implications, both for the development of new vaccines against AIDS targeting ...

HIV. Researchers have been looking for a therapeutic HIV vaccine for decades, but they have made some progress. One approach had researchers loading dendritic cells with killed AIDS viruses and ...